drug

pazopanib hydrochloride

Marketedupdated 4mo ago

by Novugen Pharma (Malaysia) Sdn Bhd

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying pazopanib hydrochloride

phase2Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Canceractive not recruitingn=51
phase2Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomasterminatedn=19

Patent cliff

source: FDA Orange Book

FDA exclusivities (1)

May 6, 2026CGTCGT

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 25m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

pazopanib hydrochloride

Marketedupdated 4mo ago

by Novugen Pharma (Malaysia) Sdn Bhd

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying pazopanib hydrochloride

phase2Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Canceractive not recruitingn=51
phase2Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomasterminatedn=19

Patent cliff

source: FDA Orange Book

FDA exclusivities (1)

May 6, 2026CGTCGT

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 25m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

pazopanib hydrochloride

all catalysts(0)

Trials studying pazopanib hydrochloride

Patent cliff

FDA exclusivities (1)

News(0)

Report a data issue

comments(0)

pazopanib hydrochloride

all catalysts(0)

Trials studying pazopanib hydrochloride

Patent cliff

FDA exclusivities (1)

News(0)

Report a data issue

comments(0)